Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 150 /hr

★★★★★

☆☆☆☆☆

Hire Heinz J.

United States

USD 150 /hr

Quantum Drug Discovery CEO | IBM Quantum | ADMET & Computational Chemistry Expert

Profile Summary

CEO and founder of Molevera, creator of BioQL — the first quantum-native drug discovery platform running 78 algorithms on IBM's 156-qubit quantum processor. I specialize in computational chemistry, ADMET profiling (207 parameters), molecular docking, lead optimization, and quantum-accelerated target analysis. Proven experience across oncology (KRAS G12C, BRAF V600E, EGFR), metabolic targets (GLP-1/Semaglutide), and rare diseases. Previously at Eurofins Scientific in life sciences services. Available for consulting on drug discovery pipelines, computational toxicology, pharmacokinetic modeling, and quantum computing applications in pharma R&D.

Subject Matter Expertise

• ☆ Molecular Modeling
• ☆ Molecular Docking
• ☆ Computational Chemistry
• ☆ Biochemistry
• ☆ Computer Science
• ☆ Quantum Computing
• ☆ Bioinformatics
• ☆ Gene & Protein Expression Analysis
• ☆ Systems Biology
• ☆ Structural Bioinformatics
• ☆ Drug Discovery
• ☆ High Throughput Screening (HTS)
• ☆ Drug Target Identification
• ☆ Hit-to-Lead & Lead Optimization
• ☆ Phenotypic Assays
• ☆ Drug Development
• ☆ In vivo Preclinical Toxicology
• ☆ Medical Toxicology

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Technical Writing

Research User Research, Meta-Research, Scientific and Technical Research, Secondary Data Collection

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Legal Consulting, Scientific and Technical Consulting

Data & AI Predictive Modeling, Statistical Analysis, Algorithm Design-ML

Product Development Formulation, Recipe Development, Deformulation, Stability/Shelf Life Testing, Product Evaluation, Material Sourcing, Product Validation, Manufacturing, Quality Assurance & Control (QA/QC), Product Compliance , Concept Development, Product Launch Support, Packaging Design, Prototyping, Reverse Engineering, Device Fabrication

Work Experience

Eurofins Scientific

- Present

CEO

Molevera

January 2026 - Present

Education

BSc in Biotechnology

Universidad Particular Inca Garcilaso de la Vega - Peru

February 2004 - December 2009

Certifications

• Biochemistry

  Peru

  January 2026 - January 2026